Release Date: 05/05/23 10:26 Summary: Final Director's Interest Notice - E Vincent Price Sensitive: No Download Document 228.62KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%